Europe direct-to-consumer laboratory testing market is projected to reach $1.59 billion by 2030
Genetic data privacy concerns, misinterpretation of test results, and lack of professional medical counselling could be challenges for the Europe direct-to-consumer laboratory testing market. However, the sample integrity and interference issues, regulatory concerns, lack of reimbursement, and limited test portfolio compared to conventional laboratory testing restrain the market’s growth.
Leave Your Comment